Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • INTU vs GSK✓SelectedUSD · GSKINTU vs GSK performance historyLatest closeAs of+1.13%11/16
Stock and ETF performance explorer

INTU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-36.3%
GSK return
+64.4%
Excess return
-100.7%
Maximum drawdown
-68.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.1%-0.1%+1.2%+1.1%
7D+2.2%-1.3%+3.5%+2.2%
30D+6.3%+2.7%+3.5%+6.2%
3M+0.4%+2.7%-2.3%+0.3%
6M-11.3%+3.3%-14.6%-11.3%
YTD-47.1%+6.5%-53.6%-47.6%
1Y-47.1%+10.7%-57.8%-47.8%
3Y-36.3%+64.4%-100.6%-35.4%
All-36.3%+64.4%-100.7%-35.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling